Related references
Note: Only part of the references are listed.Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects
H. Nelson et al.
ALLERGY (2013)
Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report
M. A. Calderon et al.
ALLERGY (2013)
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile
M. A. Calderon et al.
ALLERGY (2012)
The role of seasonal grass pollen on childhood asthma emergency department presentations
B. Erbas et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet
Harold Nelson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Effects of Ambient Pollen Concentrations on Frequency and Severity of Asthma Symptoms Among Asthmatic Children
Curt T. DellaValle et al.
EPIDEMIOLOGY (2012)
Nonlinear short-term effects of airborne Poaceae levels on hay fever symptoms
Denis M. Caillaud et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
Stephen R. Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents
Michael Blaiss et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults
Harold S. Nelson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Difference in symptom severity between early and late grass pollen season in patients with seasonal allergic rhinitis
Letty A de Weger et al.
Clinical and Translational Allergy (2011)
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Stephen R. Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Aeroallergens, Allergic Disease, and Climate Change: Impacts and Adaptation
Colleen E. Reid et al.
ECOHEALTH (2009)
Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy
Albrecht Bufe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Sub-Lingual Immunotherapy World Allergy Organization Position Paper 2009
G. Walter Canonica et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2009)
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years
Ronald Dahl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis
Ronald Dahl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis
SR Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis
R Dahl et al.
ALLERGY (2006)
Meteorologic variables in aerobiology
RW Weber
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Localization, release and bioavailability of pollen allergens: the influence of environmental factors
H Behrendt et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Comparison of pollen sampling with a Burkard Spore Trap and a Tauber Trap in a warm temperate climate
E Levetin et al.
GRANA (2000)